Sunfox Technologies will utilise the funds to expand the business PAN India, enhancing reach to last-mile users, and in scaling operations and their team.
Mumbai Angels Network, a premium platform for early-stage investments, along with Villgro USA and other investors, has invested in Sunfox Technologies, a Med-Tech R&D lab focused on developing portable, affordable, and minimalist medical devices for cardiac health. While the funding amount remains undisclosed, Sunfox Technologies will utilise the funds to expand the business PAN India, enhancing reach to last-mile users, and in scaling operations and their team.
“The pandemic has underscored the need for cutting-edge, cost-effective med-tech devices. Startups from tier-II and tier-III cities are now building high-tech solutions to solve crucial problems. Sunfox Technologies has been extremely capital efficient while making robust devices for cardiac health. It’s just the beginning of their journey, and we believe that the current round will enable them to scale their business and achieve their vision,” added. Nandini Mansinghka, Co-Founder & CEO – Mumbai Angels Network.
Rajat Jain, Founder of Sunfox Technologies, said, “At Sunfox Technologies, we have made it our mission to build cost-effective and state-of-the-art medical devices that can help patients avoid life-threatening situations and to make these devices more accessible. It is encouraging for early-stage startups to see marquee investors backing companies such as Sunfox Technologies from tier-II and tier-III cities. We are thrilled to have them be a part of our growth journey. We envision impacting grass-root users and saving over 100,000 lives from preventable heart attacks and by early diagnosis in the next few months in a pocket-friendly manner. The latest funding will help Sunfox to scale up PAN India, strengthen up the team, and foster deeper penetration till the last mile.”
“Demand for affordable and accessible care is growing exponentially. Cardiac arrests are one of the leading cause of deaths across the word and large percentage of these can be avoided by early-stage intervention. As the lead investor in Sunfox Technologies’s Spandan, an AI-powered ECG machine, I see an unparalleled affordable clinical-grade solution designed to transform cardiac care through early intervention and deliver better health outcomes.” said Nikhil Mendhi, Lead Investor for Sunfox Technologies.
Building the most innovative Med-tech devices with a vision to impact the lives of a billion last-mile users, Sunfox Technologies is a burgeoning frugal and lean hardware technologies company to bring high-end technologies to the common man with ease. The company’s flagship product is Spandan, the smallest, smartest, lightest, and most economical AI-powered ECG machine. It is a matchbox size cardiac monitoring equipment that can monitor ECG with clinical-grade accuracy, detects 40+ abnormalities with edge-based AI algorithms, needs no expertise, and can be used as a point of care device anytime, anywhere. Sunfox Technologies aims to bring reliable technologies related to Biomedical Instrumentation, IoT, and other engineering domains.
Source: Business World
